Clinical Trials at Emory University School of Medicine
As of September 2026, 43 paid clinical trials are recruiting at Emory University School of Medicine, located at 69 JESSE HILL JR DR SE, ATLANTA, GA 30303-3033, phone (404) 616-7024 in Atlanta, Georgia. Active studies at this site cover conditions such as Multiple Myeloma, Breast Cancer and Sickle Cell Disease. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
43 clinical trials at Emory University School of Medicine
·Clear filters·GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
A Study of Pitolisant in Patients With Prader-Willi Syndrome
Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA
A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment
GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Pompe Pregnancy Sub-Registry
Blue Light Cystoscopy With Cysview® Registry
A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC Deficiency
Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease
A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients
A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
Cooperative Assessment of Late Effects for SCD Curative Therapies
Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
Molecular and Cellular Characterization of Cardiac Tissue in Postnatal Development
Fecal Microbiota Transplant National Registry
Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
IMPACT: Improving Maternal Postpartum Access to Care Through Telemedicine
Extracorporeal Photopheresis in Sezary Syndrome
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
Improving Mobility After Revascularization in Peripheral Artery Disease
Common conditions studied in Atlanta
- Multiple Myeloma (28 active studies)
- Breast Cancer (21 active studies)
- Sickle Cell Disease (19 active studies)
- Schizophrenia (18 active studies)
- Acute Myeloid Leukemia (16 active studies)
- Heart Failure (15 active studies)
Leading research sponsors in Atlanta
- Emory University
- National Cancer Institute (NCI)
- AstraZeneca
- Eli Lilly and Company
- Children's Oncology Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Atlanta?
There are approximately 1,468 recruiting clinical trials in Atlanta, Georgia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Atlanta pay participants?
Most recruiting trials in Atlanta compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Atlanta?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Atlanta?
The most common conditions under active study in Atlanta include Multiple Myeloma (28), Breast Cancer (21), Sickle Cell Disease (19), Schizophrenia (18), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Atlanta?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Atlanta on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Atlanta?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Atlanta?
Recruiting research sites in Atlanta include Emory University, Emory University Hospital/Winship Cancer Institute, Emory University Hospital Midtown, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Atlanta right now?
The largest active categories in Atlanta are Cancer & tumors (450), Cardiovascular (102), Neurology & pain (80). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Emory University School of Medicine?
Emory University School of Medicine is located at 69 JESSE HILL JR DR SE, ATLANTA, GA 30303-3033. Use the Google Maps link in the intro above to get directions.
How do I contact Emory University School of Medicine?
You can reach Emory University School of Medicine by phone at (404) 616-7024. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.